Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

38.50
-1.6400-4.09%
Pre-market: 38.890.3900+1.01%04:00 EDT
Volume:1.62M
Turnover:63.41M
Market Cap:3.10B
PE:27.61
High:41.45
Open:40.36
Low:38.25
Close:40.14
52wk High:60.91
52wk Low:29.46
Shares:80.39M
Float Shares:78.97M
Volume Ratio:1.33
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.23
PE(LYR):46.95

Loading ...

Veracyte Director Jens Holstein Disposes of USD 204,747 Common Shares

Reuters
·
14 hours ago

Veracyte Adds Another Stream to Bladder Franchise, UBS Says

MT Newswires Live
·
Sep 15

Veracyte Price Target Maintained with a $66.00/Share by Freedom Capital Markets

Dow Jones
·
Sep 15

Veracyte Completes Convergent Genomics Acquisition to Expand Urology

TIPRANKS
·
Sep 15

Veracyte Buys Convergent Genomics

MT Newswires Live
·
Sep 15

Veracyte acquires Convergent Genomics for $150M in cash upfront

TIPRANKS
·
Sep 15

Veracyte Acquires Convergent Genomics, Expanding Its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform

THOMSON REUTERS
·
Sep 15

Veracyte, - Acquisition Includes $150 Mln Upfront Cash and up to $30 Mln Milestone Payments

THOMSON REUTERS
·
Sep 15

Veracyte, - Expects to Commercialize Initial Uroamp Test in Late 2028

THOMSON REUTERS
·
Sep 15

UBS Adjusts Price Target on Veracyte to $65 From $52, Keeps Buy Rating

MT Newswires Live
·
Sep 09

Veracyte Director Muna Bhanji Disposes of 1,864 Common Shares Worth $80,086.08

Reuters
·
Sep 04

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire
·
Sep 02

Veracyte (VCYT) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 24

Veracyte (VCYT) Dropped, So What Is Behind The Latest Attention?

Simply Wall St.
·
Aug 11

Veracyte price target lowered to $54 from $66 at Piper Sandler

TIPRANKS
·
Aug 04

Veracyte (VCYT) Is Down 18.2% After Raising 2026 Revenue Guidance on New Cancer Tests

Simply Wall St.
·
Aug 04

Veracyte is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 04

Guggenheim Reaffirms Their Buy Rating on Veracyte (VCYT)

TIPRANKS
·
Aug 03

Veracyte falls -24.0%

TIPRANKS
·
Jul 31

Needham Raises Price Target on Veracyte to $69 From $57, Keeps Buy Rating

MT Newswires Live
·
Jul 31